Immunogen reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acceleron Pharma XLRN:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0.17M 0.08M
Amgen AMGN:US $ 28458M 2671M
Arena Pharmaceuticals ARNA:US $ 38.78M 1.25M
Astellas Pharma 4503:JP Y 201362M 2341M
AstraZeneca AZN:LN 24601M 6727M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Cerulean Pharma CERU:US $ 0 0
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 14736.6M 1463M
Emergent Biosolutions EBS:US $ 825.2M 7.9M
Exelixis EXEL:US $ 0M 0M
Halozyme Therapeutics HALO:US $ 785.57M 0.84M
Heron Therapeutics HRTX:US $ 148.98M 148.98M
Immunogen IMGN:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 301.38M 59.58M
Macrogenics MGNX:US $ 0 0
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 26491M 908M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Seattle Genetics SGEN:US $ 0M 0M